Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05095779 · ClinicalTrials.gov registry record · Phase 2
Incentives for Oklahoma Tobacco Helpline Engagement in Persistent Poverty Counties
A Phase 2 study of Nicotine Dependence and Cigarette Smoking, sponsored by University of Oklahoma.
- Completed
- Registry status
- Phase 2
- Development phase
- 165
- Enrollment target
- 1
- Study location
NCT05095779: Completed Phase 2 study of Nicotine Dependence and Cigarette Smoking, sponsored by University of Oklahoma.
NCT05095779 is a Phase 2 study of Nicotine Dependence and Cigarette Smoking that has completed, run by University of Oklahoma. The registered enrollment target is 165 participants, below the 184-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05095779, a Phase 2 study of Nicotine Dependence and Cigarette Smoking, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 165 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed pilot project is designed to evaluate the feasibility and potential efficacy of offering small financial incentives for the completion of smoking cessation counseling and self-reported abstinence at follow-up among Oklahoma Tobacco Helpline (OTH) callers living in persistent poverty counties (PPCs). The study will enroll at least 160 adults who reside in any of the 16 persistent poverty counties in Oklahoma, who are seeking smoking cessation treatment through the OTH.
Primary Outcome
Self-reported smoking abstinence 7-day point prevalence at 12 weeks post-enrollment (missing considered smoking).
Conditions Studied
Interventions
- BEHAVIORAL Coaching calls
- BEHAVIORAL Financial Incentives
- DRUG Nicotine replacement therapy
Study Locations (1)
Oklahoma
- TSET Health Promotion Research Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2022-03-09 |
| Est. Completion | 2023-08-11 |
| Phase | Phase 2 |
What the finished NCT05095779 record still lists
NCT05095779 is an interventional study that assigns participants to a tested intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, below the 184-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (10% lower).
The record links to 2 conditions, with Nicotine Dependence appearing as the primary indexed condition, and to 3 interventions - of which Coaching calls is the first listed.
NCT05095779 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT05095779 about?
NCT05095779 is a clinical study titled "Incentives for Oklahoma Tobacco Helpline Engagement in Persistent Poverty Counties". The proposed pilot project is designed to evaluate the feasibility and potential efficacy of offering small financial incentives for the completion of smoking cessation counseling and self-reported abstinence at follow-up among Oklahoma Tobacco Helpline (OTH) callers living in persistent poverty cou...
What is the current status of trial NCT05095779?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 165 participants. The study started on 2022-03-09. Estimated completion is 2023-08-11.
What conditions does trial NCT05095779 study?
This clinical trial studies the following conditions: Nicotine Dependence, Cigarette Smoking.
What interventions are being tested in trial NCT05095779?
The interventions under investigation include: Coaching calls (BEHAVIORAL), Financial Incentives (BEHAVIORAL), Nicotine replacement therapy (DRUG).
Who is sponsoring clinical trial NCT05095779?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05095779 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05095779's enrollment target sits among peer trials
165 22nd of 67 higher than 46 of 67 other Nicotine Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nicotine Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Trial of Varenicline for E-cigarette Cessation
RECRUITING · Phase 2
-
Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity
COMPLETED · Phase 2
-
N-acetylcysteine for Tobacco Use Disorder
COMPLETED · Phase 2
-
Targeted Interventions for Weight-Concerned Smokers
COMPLETED · Phase 2
-
Adaptive Pharmacotherapy for Smoking Cessation
COMPLETED · Phase 2
-
E-cigarette Nicotine Study
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT03830320 · 165 participants · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
- NCT04289571 · 165 participants · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI